Immune System News and Research

RSS

Some tumors use two levels of protection against immune system, shows study

In research published today, Babraham Institute researchers have shown that some tumors use not one but two levels of protection against the immune system.

8 Jun 2018

Tonsil and adenoid removal increases long-term risk of respiratory, allergic and infectious diseases

Tonsil and adenoid removal associated with long-term risks of respiratory, allergic and infectious diseases Removing tonsils and adenoids in childhood increases the long-term risk of respiratory, allergic and infectious diseases, according to researchers who have examined - for the first time - the long-term effects of the operations.

7 Jun 2018

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

A class of immunotherapy drugs called checkpoint inhibitors has shown great promise against cancer in some patients.

7 Jun 2018

NCI selects Arizona State University to lead new cancer research

Arizona State University has been awarded more than $8.5 million over five years from the National Cancer Institute to establish the Arizona Cancer and Evolution Center.

6 Jun 2018

Study findings may lead to new approaches for treating inflammatory diseases

In the body, the immune system often begins its response to various attackers in the same way: the body activates immune cells, so-called phagocytes, which migrate to sites of inflammation caused by, for example, foreign pathogens or damaged tissue.

6 Jun 2018

Depression in type-1 diabetes patients linked with higher levels of inflammatory protein

Depression in type-1 diabetes patients is associated with higher levels of the inflammatory protein galectin-3, according to research published in Endocrine Connections.

6 Jun 2018

Regeneron collaborates with Zoetis to research antibody therapies for animals

Regeneron Pharmaceuticals, Inc. and Zoetis Inc. today announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.

6 Jun 2018

Study finds how colon cancer alters its genes to escape the immune system

A UCLA-led study has found how colon cancer alters its genes during development in order to avoid detection by the immune system, creating a specific genetic imprint in the process.

6 Jun 2018

Study finds new theory for gender differences in occurrence of autoimmune diseases

New findings are now being presented on possible mechanisms behind gender differences in the occurrence of rheumatism and other autoimmune diseases. The study, published in Nature Communications, can be of significance for the future treatment of diseases.

6 Jun 2018

Study demonstrates that HIV infection in the brain can be established, maintained by T cells

A new study by University of North Carolina School of Medicine researchers has found that T cells, a type of white blood cell and an essential part of the immune system, are sufficient by themselves to establish and maintain an HIV infection in the brain.

6 Jun 2018

Research project could lead to development of new immune therapies for lung cancer

Protein kinases regulate nearly all processes in cells. If the function of these enzymes is disrupted, often cancer will develop. In particular certain types of deregulated mitogen-activated protein kinases are believed to be the cause of various types of cancer.

5 Jun 2018

Altering bacteria’s genetic code may pave way for long-lasting drugs, shows study

By altering the genetic code in bacteria, researchers at The University of Texas at Austin have demonstrated a method to make therapeutic proteins more stable, an advance that would improve the drugs' effectiveness and convenience, leading to smaller and less frequent doses of medicine, lower health care costs and fewer side effects for patients with cancer and other diseases.

5 Jun 2018

Researchers investigate if stabilization of ovarian hormones can reduce suicide risk

A three-year, $750,000 grant from the National Institutes of Mental Health will help researchers determine whether the stabilization of ovarian hormones estradiol and progesterone can help lower symptoms associated with suicidality among females at risk for suicide.

5 Jun 2018

New study shows how alcohol contributes to development of Alzheimer's disease

Research from the University of Illinois at Chicago has found that some of the genes affected by alcohol and inflammation are also implicated in processes that clear amyloid beta -- the protein that forms globs of plaques in the brain and which contributes to neuronal damage and the cognitive impairment associated with Alzheimer's disease.

5 Jun 2018

Study sheds new light on how the food we eat affects biochemical signals in the gut

For years, researchers have studied how the body's microbiome impacts virtually every aspect of human health ranging from the immune system to mental wellness.

5 Jun 2018

Breast cancer treated successfully with immune therapy

According to researchers from the US, early breast cancers can be successfully treated with a new form of immune therapy instead of traditional chemotherapy. The details of the treatment and the case is published in the journal Nature Medicine.

5 Jun 2018

Researchers establish versatile, powerful model to analyze human cancer

Fuyuhiko Tamanoi of Kyoto University's Institute for Integrated Cell-Material Sciences and colleagues in the US succeeded in establishing a versatile, powerful and convenient model to analyze human cancer.

4 Jun 2018

Researchers identify racial differences in breast cancer immune microenvironment

Roswell Park Comprehensive Cancer Center researchers have identified significant differences in the immune microenvironment of breast cancer tumors between African-American and white women, shedding light on the ways in which race can influence cancer development and outcomes.

4 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

The University of Texas MD Anderson Cancer Center and Amgen today announced two multi-year collaboration agreements aimed at accelerating development of a variety of Amgen's early-stage oncology therapies for patients with leukemia, myelodysplastic syndromes, multiple myeloma, small-cell lung cancer, and other non-lung cancers with small-cell histologies.

1 Jun 2018

Immune System News and Research

Some tumors use two levels of protection against immune system, shows study

Tonsil and adenoid removal increases long-term risk of respiratory, allergic and infectious diseases

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

NCI selects Arizona State University to lead new cancer research

Study findings may lead to new approaches for treating inflammatory diseases

Depression in type-1 diabetes patients linked with higher levels of inflammatory protein

Regeneron collaborates with Zoetis to research antibody therapies for animals

Study finds how colon cancer alters its genes to escape the immune system

Study finds new theory for gender differences in occurrence of autoimmune diseases

Study demonstrates that HIV infection in the brain can be established, maintained by T cells

Research project could lead to development of new immune therapies for lung cancer

Altering bacteria’s genetic code may pave way for long-lasting drugs, shows study

Researchers investigate if stabilization of ovarian hormones can reduce suicide risk

New study shows how alcohol contributes to development of Alzheimer's disease

Study sheds new light on how the food we eat affects biochemical signals in the gut

Breast cancer treated successfully with immune therapy

Researchers establish versatile, powerful model to analyze human cancer

Researchers identify racial differences in breast cancer immune microenvironment

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News